Ohr Pharmaceutical Announces Strategic Update and Fiscal First Quarter 2017 Earnings
February 14, 2017 07:00 ET
|
Ohr Pharmaceutical, Inc.
Management to Host a Conference Call and Webcast at 7:45a.m Eastern Time Today NEW YORK, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical...
TiGenix annonce la nomination du Dr June Almenoff au conseil d'administration
September 22, 2016 01:00 ET
|
TiGenix
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COMMUNIQUÉ DE PRESSE TiGenix annonce...
TiGenix stelt dr. June Almenoff aan als lid van de Raad van Bestuur
September 22, 2016 01:00 ET
|
TiGenix
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
PERSBERICHT TiGenix stelt dr. June...
TiGenix Appoints Dr. June Almenoff to its Board of Directors
September 22, 2016 01:00 ET
|
TiGenix
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
PRESS RELEASE TiGenix Appoints Dr....
Ohr Pharmaceutical to Present at Upcoming Investment Conferences
March 02, 2016 14:45 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, March 02, 2016 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that Dr. Jason Slakter, Chief Executive...
Ohr Pharmaceutical to Present at the LEERINK Partners 5th Annual Global Healthcare Conference in New York
February 09, 2016 09:48 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Feb. 09, 2016 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that Dr. Jason Slakter, Chief Executive...
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
August 05, 2015 08:00 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company announced today that Jason S. Slakter, MD, has been appointed Chief...
Ohr Pharmaceutical to Present at the 35th Annual Cowen & Company Health Care Conference
March 03, 2015 08:00 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, March 3, 2015 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that Dr. Irach Taraporewala, Chief Executive...
Ohr Pharmaceutical Announces Closing of Public Offering of Common Stock
February 11, 2015 12:54 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Feb. 11, 2015 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, announced today that it has closed its previously announced...
Ohr Pharmaceutical Reports Fiscal First Quarter 2015 Financial and Business Results
February 09, 2015 16:01 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Feb. 9, 2015 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today reported results for its first fiscal quarter ended December...